Duchenne Muscular Dystrophy (DMD)

DMD: Idebenone Slows Decline of Respiratory Function

DMD: Drisapersen Dosing Planned for Later in 2014

DMD: Encouraging Results for SMT C1100

DMD: Ataluren May Get Conditional Approval in Europe

DMD: Sarepta Will Pursue Accelerated Approval for Eteplirsen and Conduct Additional Trials

Tadalafil, Sildenafil Increase Blood Flow to DMD-Affected Muscles

A Landmark Development for the Duchenne MD Community

DMD: Prosensa Pursuing Path Forward for Drisapersen

MDA Thrilled FDA Will Consider Accelerated Approval for New Muscle Disease Drug Aimed at DMD

New Forms of Genetic Testing Improve Diagnosis, Raise Questions

“Knowing, if not all, is almost all,” said Matthew Harms, a neurologist and neurophysiologist from Washington University in St. Louis, in his presentation on genetic testing for neuromuscular disorders at the 2014 MDA Clinical Conference, held in Chicago March 16-19.

Pages